Lazarus Therapeutics

Lazarus Therapeutics developed neurological disease therapeutics for patients suffering from Parkinson’s disease.

Lazarus Therapeutics LLC, an early-stage biopharmaceutical company, develops therapeutics for neurological diseases. It focuses on developing therapies for patients at various stages Parkinson's diseases. The company offers neuroprotective/neurorestorative therapies for early stage Parkinson's disease; levodopa-enhancing and anti-dyskinesia therapy for mid-stage patients; and gene therapies for advanced patients. Lazarus Therapeutics LLC was incorporated in 2006 and is based in West Chester, Pennsylvania.